Lupus Flares and Histological Renal Activity at the End of the Treatment (LuFla)

• Conditions: Lupus Nephritis

• Registration Number: NCT02313974
• Lead Sponsor: Hospital de Clinicas José de San Martín

Brief Summary

At this moment, the duration of the treatment in Proliferative Lupus Nephritis has not been determined.

Almost 30 percent of patients in total remission during or after a treatment, will relapse in the first 5 years.

The factors associated to Renal relapses are not completly known. The investigators think that an histological control study performed to patient with complete remission for a year at the end of a 3 years treatment could help us to know which patients are going to relapse.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01
• Study First Submitted: 2014-12-08
• Study First Submitted QC: 2014-12-09
• Study First Posted: 2014-12-10
• Status Verified: 2016-09
• Last Update Submitted: 2016-09-12
• Last Update Posted: 2016-09-14
• Primary Completion: 2016-11
• Study Completion: 2018-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Renal Flares	2 years	Renal relapse after a complete treatment in complete remission patients

Trial Locations

Locations (1)

Hospital de Clinicas; 🇦🇷 Buenos Aires, Caba, Argentina